chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Info has been received from a health professional concerning a 6 year old Hispanic male, who developed a rash to penicillin, who, on 4/22/05, was vaccinated with a 1st dose in the left deltoid of varicella virus vaccine live. There was no illness at the time of vaccination. It was reported that on 4/25/05, the pt presented with about 100 vesicular lesions and no other symptoms. At the time of the report, the pt was recovering. There were no lab or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Follow-up info from a health professional indicated that on 4/23/05, the pt broke out in about 100 vesicles on his trunk, arms and face one day after vaccination with varicella virus vaccine live. It was reported that the pt recovered within 2 weeks. Additional info is not expected.
Experienced tingling of tongue and lips 20 minutes after injection of vaccine.   Zyrtec 10mg PO given, with symptoms resolved after 35 minutes.
received dose that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis.   On 14th July 2022, the patient received Engerix B. On 14th July 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     Additional Information: GSK receipt date: 15-Jul-2022 Reporters comment: The reporter consented to follow up. Additional Supportive Information: The patient received expired dose of Engerix B, which led to expired vaccine used. This case was linked with case US2022107251, reported by the same reporter.; Sender's Comments:  US-GSK-US2022107251:Same reporter
Fever, chills, nausea for 18 hours. Barely able to leave bed for bathroom unassisted.
Patient is mainly concerned about left-sided pain.  She states that she got the Pfizer COVID vaccine 2nd dose on 04/23/2021.  Two days later she started developing neck pain with stiffness in the neck shoulder pain and arm and forearm pain with numbness and pain over her left hand.  Soon thereafter she also started getting left hip pain and left leg pain going into her knee.  This has been present over the last 2 months though she feels that in the last 2 weeks it has relented and improved though it still continues to be present.  She has difficulty sleeping on account of this.  She denies similar problems prior to the vaccine.  She states that she tried to go on to the vaccine adverse event for reporting System website but could not report this and hence tried to ask the clinic as to how she would do it.
Headache on the next morning/ Another headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache on the next morning/ Another headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 6:00 AM, the patient experienced HEADACHE (Headache on the next morning/ Another headache). The patient was treated with CAFFEINE, PARACETAMOL (PARACETAMOL EXTRA [CAFFEINE;PARACETAMOL]) for Headache, at a dose of UNK, qd for 2 days. At the time of the report, HEADACHE (Headache on the next morning/ Another headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  The patient had headache on the next day of vaccination which went away with in 4-5 hours after taking two paracetamol (extra strength). On 11-Mar-2021, the patient had another headache. According to the patient, it was not as bad but was not going away. The patient took two paracetamol (extra strength) again.
rash; right eye seeps as if infected; allergic reaction; agitation; diarrhea; insomnia; lymphadenopathy; chickenpox; unspecified disability; legs sore; loss of appetite; cries of pain; Information has been downloaded from regulatory authority (HQ2900705JUL2001)  This spontaneous report was received from a healthcare professional referring to a 7-month-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were not reported.   On 20-NOV-2000, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (1 dosage form daily (qd) by subcutaneous route); and also with pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197)(PREVNAR) injection (1 dosage form daily by intramuscular route); poliovirus vaccine inactivated (unspecified) (1 dosage form daily); diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid injection (1 dosage form daily by intramuscular route); and hib conj vaccine (crm197) injection (1 dosage form daily by intramuscular route). All suspect vaccines indicated for immunization.  Strength, dose, anatomical location, lot #, and expiration date were not reported for all vaccines.  On 20-NOV-2000, the patient experienced legs sore (pain in extremity), cries of pain (crying), and loss of appetite (decreased appetite).  On an unknown date, the patient experienced unspecified disability (disability), chickenpox (varicella), lymphadenopathy, insomnia, diarrhoea, agitation,  allergic reaction (hypersensitivity), right eye seeps as if infected (eye infection), and rash (dermatitis).      The outcome of disability, varicella, lymphadenopathy, insomnia, diarrhoea, agitation, hypersensitivity, eye infection, dermatitis, crying, decreased appetite, and pain in extremity was unknown.  The causal relationship between the events and suspect vaccines were not reported.  According to the agency, all events were considered serious due to the disability.
She start today with coughing; she is coughing and coughing; this coughing is really bad; coughing too much; After the shot she feels tired then during in the night; Her heart; heartbeat go more faster; She feel weak; Headache; She is very down; She do not want to eat; she feel like nausea; This is a spontaneous report from a contactable consumer (Parent). A 12-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, consumer stated that Yesterday we went to Pharmacy and put their vaccine for my daughter 12-year-old. Yesterday she was prefect, but she started today with coughing and consumer didn't find anywhere, consumer read all the information about it was Pfizer vaccine. Consumer didn't find the coughing. She felt tired, her heart and this moment, it was like heartbeat go more faster and she was coughing and coughing, and she felt weak. But consumer read a cough was normal. But consumer didn't find the coughing.  She was coughing. Yesterday she was perfect. After the vaccine, this morning she started coughing. Consumer wanted to know if this coughing could be normal for the vaccine or consumer have to take it her to doctor or consumer have to take it to hospital. Because she was coughing was really bad. She got a headache; she was very down. Her heart was got a like a fast, feel like a little bit faster. Consumer believed she was coughing too much consumer don't know. But yesterday she was perfect. After the shot she feels tired then during in the night. And this morning she start with the coughing. Consumer gave Tylenol (treatment) to her, she started with the headache. She did not want to eat. She felt like a nausea. The outcome of events was unknown.  The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow-up.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a adult female patient who received SHINGRIX (batch number KB99G, expiry date 22nd February 2021) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced fever, general body pain and injection site pain. On an unknown date, the outcome of the fever, general body pain and injection site pain were unknown. It was unknown if the reporter considered the fever, general body pain and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received dose 1 of SHINGRIX and reported symptoms of fever, body aches, injection site pain starting the day after injection and lasting approximately for 24 hours. The patient then reported another episode of these symptoms few days later, which lasted up to 3 days. The reporter did not give consent to follow up. The health care professional contacted to GSK, because the patient thought it was unusual to had a second round of adverse events after being symptom free for a few days.
Headache the day of vaccination Following morning, thought everything was fine; walked outside and suddenly felt very lightheaded and unbalanced - enough so that I momentarily completely lost my balance and hit my head on a metal bracket overhead.
Admitted for COVID and sepsis 2/2 ? acute cystits. Vaccine completed in Apr 2021. No focal covid symptoms. Rocephin, doxy, lovenox, vanc. Not requiring O2. The case was discussed with infectious disease on the day of discharge.  She is discharged today in improved condition.  Notably she did have headache during the admission which was evaluated with CT scan that showed no acute pathology and which was characteristic of the patient's historic migraines.  On the day of discharge he also noted a knot under like a bruise on her left abdomen.  She noted a history of abscesses in the past.  Lesion was palpated while tender was not exquisitely so.
4 days after receiving an injection patient began to experience a sore throat which progressed into a sinus infection by the next day and lasted for 5 days. On day 6 the patient began to experience dizziness, tinnitus, fever and aching joints. The night of day 7 the fever worsened at night and then broke and disappeared over the course of the next day, along with the joint aches and dizziness. On the eighth day the patient noticed an unidentified rash on the outer pinna of both ears that has continued without abate until the present (day 11).
This spontaneous report has been received from an office manager refers to an unspecified number of patents of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of VAQTA (lot # K026529, exp. date on 02-JUN-2017), (strength, route of administration and dose were not provided). There was no concomitant medication reported. This is one of several reports received from the same reporter. Additional information has been requested.
Syncope, drunk water and been under observation. Looks great and let home with her father. Pulse 92 SPO2 98 BP 102/66
101.6 temp; headaches; chills; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of body temperature increased in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced body temperature increased (Verbatim: 101.6 temp), headache (Verbatim: headaches) and chills (Verbatim: chills). The outcome of the body temperature increased, headache and chills were not reported.   It was unknown if the reporter considered the body temperature increased, headache and chills to be related to Shingles vaccine.  It was unknown if the company considered the body temperature increased, headache and chills to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that just got the shingles shot and 101.6 degree F temperature, headaches, chills horrific long night. The follow up would not possible as no contact details were available.
Starting with the first Phizer covid shot I started experiencing fatigue, brain fog, balance control. headaches in the back of my head (which I never had before the shots), and not wanting to do anything, The "side effects" have been getting worse as time goes on. First shot 06/11/21. second shot 07/02/21, booster 01/12/22
Information has been received from a nurse concerning a female who was vaccinated with Gardasil.  There was no illness reported at the time of vaccination.  The patient had not eaten breakfast.  Subsequently, the patient fainted after receiving the vaccine.  The patient did not seek medical attention.  Subsequently, the patient recovered from fainting.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2008. Initial and follow up information has been received from a registered nurse concerning a 19 year old white female with drug hypersensitivity to codeine and environmental allergies who on 11-JAN-2008 was vaccinated with her first dose of 0.5 ml GARDASIL (Lot #655154/1220U) intramuscularly in the left deltoid at 10:00 am. There was no illness reported at the time of vaccination. Two to three minutes after the injection the patient felt dizzy and passed out. Her vital signs remained stable. The patient stated that she had not eaten yet an d felt better after eating and drinking something. The patient recovered on 11-JAN-2008. No further information is expected.
Significant swelling of outer arm (close to injection site) a week after injection. Swelling appears hard, with reduced mobility in arm. Similar to a significant reaction to a mosquito bite.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The patient has no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Treatment of COVID-19. Therapeutic measures, Paxlovid from 28Dec202 to 02Jan2023, were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Dizziness and vertigo, particularly when turning head to the left.  Began the evening of the second dose, and continued on for 5 additional days. This was above and beyond the other effects:  chills, low grade fever for 36 hours, fatigue, headache.
no adverse effects; The nurse reported that the patient, who is 16 years old, was given one dose of VAQTA 50/1.0 U/ml; This spontaneous report was received from a nurse concerning a 16 year old patient. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions.  On 07-OCT-2019, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA), 1 dose (50/ 1.0 U/ml), via intramuscular, lot # R024008, expiration date 15-NOV-2019  for prophylaxis (frequency and anatomical location were not reported) (incorrect dose administered). No adverse effects were reported
no appetite; Chills; Diarrhea; Fatigue; Pain in arm; Cough; Nasal congestion; This is a spontaneous report from a contactable Nurse (patient herself). A 87-years-old female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EL3249; Expiration Date: May2021) intramuscularly administered in right deltoid on 02Feb2021 at 0.3 ml single, for COVID-19 immunization. Medical history included hypertension (she had hypertension, or high blood pressure, which she was treated for). There were no concomitant medications. Caller says she has not had any other recent vaccinations or started any new medications. On 02Feb2021, the patient experienced cough, nasal congestion, fatigue and pain in arm, on an unspecified date, patient experienced chills, diarrhoea and no appetite. Retired RN (registered nurse) called as patient about the Pfizer COVID-19 vaccine, who says she was wondering about the shot that she got the first dose of last Tuesday. She says she has been looking at the sheet of side effects etc, and she had cough, which was not listed, and nasal congestion, no appetite, chills, and diarrhoea started on the second or third day after getting the vaccine. Caller says her cough started when she came home, and she was really exhausted after that, the cough was not bad. She asks if the vaccine is made in Germany. She says that the fatigue and pain in her arm lasted three days. Caller says that she feels it is medically significant, and she is not going back for the second shot. She took Mucinex for the nasal congestion, and for her diet she ate soup. Caller says this medication was over the counter and not prescription. Caller says that she feels it is medically significant, and she is not going back for the second shot. The outcome of the events was unknown.
Mon, Jan 14 10:45am - Immunization SHINGRIX, easy, virtually pain free injection; 2:00pm - sore/achy injection site. Pain when lifting arm. No redness or swelling. 5:00pm - 99 fever. Normal body temperature is 97.6 (Not 98.6) 7:00pm - 100 fever, chills, muscle aches, joint pain, light abdominal pain  10:00pm - 102.5 fever, extremely painful joints, hot, chilled 2:00am - 102.5 fever, took 2 advil (didn't help much) Tues, Jan 15 9:00am - 101.5 fever, headache began, still sore muscles & joints 2:00pm - 100 fever, took 2 acetaminophen 3:00pm - 99.5 fever, symptom relief occurring 5:00pm - 99 fever, symptom relief continues Wed, Jan 16 9:00am - 99 fever, no aches, no joint pain, no headache,  injection site sore to the touch but not for movement I slept or was laying down the entire time during this reaction to the immunization. It rendered me unable to perform my daily activities.
Slower heart rate, heart pain, chest tightness, brain fog, paranoia, sleep phobia, headache
this is 1 of 6 pt from this site to have n unspecified adverse exp p/Td vax;
This spontaneous report was received from a medical assistant refers to a patient of unknown age. On an unknown date, the patient was vaccinated with improperly stored doses of varicella vaccine live VARIVAX, lot # M000996, expiry date 07-JAN-2018. No adverse reactions were reported. Additional information has been requested.
Received the injection at 10:30 on Friday morning 2/5/21..  I started a regimen of ibuprofen 800mg alternating with Tylenol 1000mg afterwards. I began with a fever of 101.2 at 1:00 am on 2/6/21.  Began having severe chills, shaking, and nausea despite taking ibuprofen 800mg alternating with Tylenol 1000 mg.  At 5:30 am I had a temperature of 102.4 with sweats and continued body aches, shaking, and nausea. During the day of 2/6/21 my Temperature stayed just around 100.6 and I had body aches and fatigue.  During the night my fever went up again to 101.6.  On 2/7/21 I have not had fever, however, I have a red raised area where the vaccine was given. I also have a red lacy rash on my neck, chest, arms, stomach, and back. The rash is prickly and itches.  It worsened when I got into a warm shower.
Moderna Dose 1 3/16/21 (026A21A) Moderna Dose 2 4/13/21 (040B21A) Moderna Dose 3 11/23/21 (NA) COVID Positive 1/5/22 COVID Positive 1/15/22 1/15/22: Symptoms started around 03:00 o'clock yesterday afternoon. She had abdominal pain followed by vomiting. Last bowel movement was yesterday morning and was normal. Since onset of symptoms, patient does not recall having passed any flatus. She presented to the emergency room early this morning. Labs were generally unremarkable. CT scan demonstrated findings consistent with a high-grade small-bowel obstruction with transition point in the right mid abdomen. The overnight read suggested the possibility of a second transition point at periumbilical hernia. The over read by our in-house radiologist did not think there was a transition point at the hernia. Patient has had an NG tube placed in the emergency room. She is still having pain, but notes that it is mildly improved. 1/19/22: Patient was admitted with CT confirmed evidence of a small-bowel obstruction. After 1 day of conservative management, she was not showing signs of resolution. She was taken to the operating room. She was found to have an internal hernia caused by her cecum flopping over towards the left side of her abdomen. Her cecum was hyper mobile. There was nothing actually tethering it down like this. I performed a cecopexy. Postoperatively, she recovered quickly, passing flatus 2 days after the surgery and then having a bowel movement. Her diet was advanced stepwise. She was deemed ready for discharge 3 days after the surgery.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/27/2023 HTN (HYPERTENSION) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/27/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE
Eight days after the vaccine, I got a rash on my upper right arm. It is itchy, red, and painful.
about 12 hours after vaccine administration patient c/o red raised rash in approximately 3 in" area around injection site. BEANDRYL administered by patients mother.
poss GBS started w/bilateral facial palsy & weakness in rt arm; had diminished or absent reflexes in lower extremities; pt was hospitalized in 2 different hospitals;  non-conclusive neuro findings; GBS is r/o dx; still c/o weakness;
Ongoing diarrhea, cramping, stomach pain, gas, mucus in stool.
patient wife came in to state that patient experienced fever, body aches, chills and sweating. injection site was hot and swollen, entire arm hurt
I'm in unbearable pain in my lower back; feel like I am dragging my right leg; This is a spontaneous report from a Regulatory Authority. A female consumer (patient) of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. It was reported that, patient was in horrible reaction to the second dose of the COVID shot she was in unbearable pain in lower back and feel like she was dragging her right leg on an unspecified date. The outcome of both the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.